Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas-Reference-Cited by-同舟云学术

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

Published:2013-11-03 Issue:12 Volume:45 Page:1470-1473
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Jiao Yuchen,Pawlik Timothy M,Anders Robert A,Selaru Florin M,Streppel Mirte M,Lucas Donald J,Niknafs Noushin,Guthrie Violeta Beleva,Maitra Anirban,Argani Pedram,Offerhaus G Johan A,Roa Juan Carlos,Roberts Lewis R,Gores Gregory J,Popescu Irinel,Alexandrescu Sorin T,Dima Simona,Fassan Matteo,Simbolo Michele,Mafficini Andrea,Capelli Paola,Lawlor Rita T,Ruzzenente Andrea,Guglielmi Alfredo,Tortora Giampaolo,de Braud Filippo,Scarpa Aldo,Jarnagin William,Klimstra David,Karchin Rachel,Velculescu Victor E,Hruban Ralph H,Vogelstein Bert,Kinzler Kenneth W,Papadopoulos Nickolas,Wood Laura D

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2813.pdf

Reference21 articles.

1. Everhart, J.E. & Ruhl, C.E. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology 136, 1134–1144 (2009).

2. Blechacz, B. et al. Clinical diagnosis and staging of cholangiocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 8, 512–522 (2011).

3. Borger, D.R. et al. Frequent mutation of isocitrate dehydrogenase IDH1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17, 72–79 (2012).

4. Voss, J.S. et al. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Hum. Pathol. 44, 1216–1222 (2013).

5. Xu, R.F. et al. KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients. Biomed. Pharmacother. 65, 22–26 (2011).

Cited by 570 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial transcriptomics profiling of gallbladder adenocarcinoma: a detailed two-case study of progression from precursor lesions to cancer;BMC Cancer;2024-08-20

2. Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches;Cancers;2024-08-20

3. AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma;Cell Death & Differentiation;2024-08-14

4. Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers;JCO Precision Oncology;2024-08

5. Tubulocystic Carcinoma of Bile Ducts;American Journal of Surgical Pathology;2024-07-01